These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6995209

  • 1. Effect of sulphated polysaccharides on prostacyclin (prostaglandin I2)-induced inhibition of platelet aggregation [proceedings].
    Kindness G, Williamson FB, Long WF.
    Biochem Soc Trans; 1980 Jun; 8(3):377-9. PubMed ID: 6995209
    [No Abstract] [Full Text] [Related]

  • 2. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI, Saba SR, Blackburn CA, Hartmann RC, Mason RG.
    Science; 1979 Aug 03; 205(4405):499-501. PubMed ID: 377493
    [Abstract] [Full Text] [Related]

  • 3. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
    MacIntyre DE, Handin RI, Rosenberg R, Salzman EW.
    Thromb Res; 1979 Aug 03; 22(1-2):167-75. PubMed ID: 6270842
    [No Abstract] [Full Text] [Related]

  • 4. A prospective method for thrombotic diseases using prostaglandin I2.
    Isobe J, Mizuno A.
    Tokushima J Exp Med; 1982 Jun 03; 29(1-2):95-101. PubMed ID: 6755803
    [No Abstract] [Full Text] [Related]

  • 5. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
    Jørgensen KA, Dyerberg J, Stoffersen E.
    Thromb Res; 1980 Sep 15; 19(6):877-81. PubMed ID: 6258262
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL, Harker LA, Andersen NH, Wilson CH.
    Adv Prostaglandin Thromboxane Res; 1980 Sep 15; 6():389-93. PubMed ID: 6247888
    [No Abstract] [Full Text] [Related]

  • 7. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F, Camussi G.
    Prostaglandins; 1980 Nov 15; 20(5):781-91. PubMed ID: 6258196
    [Abstract] [Full Text] [Related]

  • 8. [Effect of heparin and prostacyclin on blood platelet activity].
    Kisiel S, Myśliwiec M, Jakubowska I, Rydzewski A.
    Pol Tyg Lek; 1983 Jun 13; 38(24):717-20. PubMed ID: 6359097
    [No Abstract] [Full Text] [Related]

  • 9. Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation.
    Jørgensen KA, Dyerberg J, Stoffersen E.
    Pharmacol Res Commun; 1979 Jul 13; 11(7):605-15. PubMed ID: 388470
    [No Abstract] [Full Text] [Related]

  • 10. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
    Briel RC, Lippert TH.
    Eur J Obstet Gynecol Reprod Biol; 1981 Jun 13; 12(1):19-23. PubMed ID: 7018952
    [Abstract] [Full Text] [Related]

  • 11. In vitro inhibition by endotoxin of the anti-aggregatory action of prostacyclin produced by aortic rings.
    Bult H, Herman AG.
    Arch Int Pharmacodyn Ther; 1978 Aug 13; 234(2):335-6. PubMed ID: 361006
    [No Abstract] [Full Text] [Related]

  • 12. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
    Marmo E, Somma A, Ottavo R, Vairo G, Spaziante G, DiMezza F, Paone G.
    J Med; 1981 Aug 13; 12(2-3):97-108. PubMed ID: 7024451
    [No Abstract] [Full Text] [Related]

  • 13. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H, Hirata T, Sugawara H, Sugai K, Yoda B, Toyota T, Goto Y.
    Tohoku J Exp Med; 1982 Aug 13; 137(4):423-8. PubMed ID: 6750843
    [Abstract] [Full Text] [Related]

  • 14. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
    Bertelé V, Roncaglioni MC, Donati MB, de Gaetano G.
    Thromb Haemost; 1983 Apr 28; 49(2):81-3. PubMed ID: 6346573
    [Abstract] [Full Text] [Related]

  • 15. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
    Roncaglioni MC, Bertelé V, de Gaetano G, Donati MB.
    Thromb Res; 1983 Jul 15; 31(2):397-400. PubMed ID: 6356460
    [No Abstract] [Full Text] [Related]

  • 16. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A, Stierle A, Anton R, Cazenave JP.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3597-600. PubMed ID: 6295405
    [Abstract] [Full Text] [Related]

  • 17. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J, Parkinson S, Timmons S.
    Nature; 1980 Jan 10; 283(5743):195-7. PubMed ID: 6985716
    [Abstract] [Full Text] [Related]

  • 18. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
    Haslanger MF, Sprague PW, Snitman D, Vu T, Harris DN, Greenberg R, Powell J.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Jan 10; 11():293-7. PubMed ID: 6221540
    [No Abstract] [Full Text] [Related]

  • 19. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K, Sinzinger H, Schernthaner G, Silberbauer K, Prager R.
    Wien Klin Wochenschr; 1981 Jul 10; 93(14):460-2. PubMed ID: 7023074
    [Abstract] [Full Text] [Related]

  • 20. Effects of PGI2 on platelet aggregation induced by various stimulants.
    Ohtsu A, Hoshina K, Kurozumi S, Hashimoto Y, Noguchi T, Nicolaou KC.
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug 10; 42(4):659-66. PubMed ID: 388963
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.